Lee, Fa Chyi External Entity

Publications

Sort by

Selected publications

  • Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer.  PloS one2013 Academic Article GET IT

Other